Skip to main content
. Author manuscript; available in PMC: 2019 Jul 2.
Published in final edited form as: Behav Brain Res. 2017 Dec 8;346:21–28. doi: 10.1016/j.bbr.2017.12.008

FIG. 6.

FIG. 6

Circulating leukocyte counts, 3 months-post MTX+AraC administration. After MTX+AraC exposure, the number of circulating leukocytes per ml of blood increased. * p < 0.05.